Controlling SIRT1 expression by microRNAs in health and metabolic disease

Jiyoung Lee, Jongsook Kim Kemper

Research output: Contribution to journalArticlepeer-review


SIRT1 is a NAD+-dependent deacetylase implicated in longevity and diverse physiological processes. SIRT1, as a key mediator of beneficial effects of caloric restriction, regulates lipid and glucose metabolism by deacetylating metabolic regulators, as well as histones, in response to nutritional deprivation. Here we discuss how SIRT1 levels are regulated by microRNAs (miRs) which are emerging as important metabolic regulators; the recently identified nuclear receptor FXR/SHP cascade pathway that controls the expression of miR-34a and its target SIRT1; and a FXR/SIRT1 positive feedback regulatory loop, which is deregulated in metabolic disease states. The FXR/miR-34a pathway and other miRs controlling SIRT1 may be useful therapeutic targets for age-related diseases, including metabolic disorders.

Original languageEnglish (US)
Pages (from-to)527-534
Number of pages8
Issue number8
StatePublished - Aug 2010


  • And metabolic syndrome
  • FXR
  • SHP
  • SIRT1
  • miR-34a
  • p53

ASJC Scopus subject areas

  • Aging
  • Cell Biology


Dive into the research topics of 'Controlling SIRT1 expression by microRNAs in health and metabolic disease'. Together they form a unique fingerprint.

Cite this